MANE

$136.66

+7.51% Oct 21 close

Sector n/a Compare

1M 3M 6M 1Y 2Y

MANESPY

+20.4%

+21.2%

+24.4%

+94.4%

YTD

–

Live chart

Loading live chart…

What they do

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy.

Healthcare · Biotechnology

For information only · Important disclosures

Grades vs sector

No sector grades for MANE yet. Grades rank S&P 1500 stocks within their sector and refresh after each daily data run, so a stock outside that index or newly covered has none.

Our models

Not held by any of our 5 live models right now.

Quality Growth

Outside this model's universe or screens

Momentum Top 15

Outside this model's universe or screens

Momentum Blend

Not in the current book

New Highs Growth

Outside this model's universe or screens

Coteau Long Book

Not in the current book

News

More news

Roche inks $15B ADC pact with Hansoh; Veradermics scores in another baldness study

BioPharma Dive · Oct 19

Key stats

52-week range$37.03 – $136.66

Valuation and fundamentals

Valuation & fundamentals

No US-GAAP 10-K/10-Q financials in SEC data (foreign filers report on Form 20-F, often under IFRS).

Earnings

Next report: 2026-11-12 · before open · EPS est -0.62

EstimateActual (beat)Actual (miss)

Report	EPS est	Actual	Surprise
2026-08-11	-0.64	-0.58	+9.6%
2026-03-30	-18.24	-104.54	-473.1%

Insider trades

Montanova Capital, Llc

Director · 2026-08-19

Sell
$6.4M

Montanova Capital, Llc

Director · 2026-08-19

Sell
$74.1M

Waldman Reid Alexander